Mack David Henry 4
4 · PMV Pharmaceuticals, Inc. · Filed Jul 3, 2025
Insider Transaction Report
Form 4
Mack David Henry
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-07-01$1.06/sh−58,411$62,179→ 536,133 total
Holdings
- 147,915(indirect: See footnote)
Common Stock
- 165,307(indirect: See footnote)
Common Stock
- 56,978(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.
- [F2]Includes 15,528 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025.
- [F3]The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F4]The shares are held of record by the Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F5]The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.